Re: Friedreich’s Ataxia Therapy News - Very interesting
|
5
|
Resverlogix Corp.
|
May 26, 2017 02:27PM
|
Re: From 2018.
|
3
|
Resverlogix Corp.
|
May 03, 2020 12:09PM
|
Re: From CRP to IL-6 to IL-1: Moving Upstream To Identify Novel Targets for Atheroprotection
|
3
|
Resverlogix Corp.
|
May 11, 2019 10:52PM
|
Re: From CRP to IL-6 to IL-1: Moving Upstream To Identify Novel Targets for Atheroprotection
|
4
|
Resverlogix Corp.
|
May 11, 2019 11:26PM
|
Re: From gv on SH
|
3
|
Resverlogix Corp.
|
Jan 04, 2016 03:39PM
|
Re: From IR re: Prospectus Offering and Corporate Presentation
|
2
|
Resverlogix Corp.
|
May 23, 2019 04:16PM
|
Re: from J4P on SH , "I will go out on a limb with a prediction..." Good, Better, Best and Share price
|
4
|
Resverlogix Corp.
|
Mar 07, 2021 10:08AM
|
Re: From the NKF Facebook Page...
|
6
|
Resverlogix Corp.
|
Feb 25, 2020 10:40AM
|
Re: From the NKF Facebook Page...
|
5
|
Resverlogix Corp.
|
Feb 25, 2020 12:26PM
|
Re: From the NKF Facebook Page...
|
1
|
Resverlogix Corp.
|
Feb 25, 2020 12:46PM
|
Re: From the NKF Facebook Page...
|
1
|
Resverlogix Corp.
|
Feb 25, 2020 01:35PM
|
Re: From today's WSJ...Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, Merck Shionogi starts human trials
|
3
|
Resverlogix Corp.
|
Jul 28, 2021 07:47AM
|
Re: Full Poster Abstract
|
4
|
Resverlogix Corp.
|
Sep 02, 2015 01:57PM
|
Re: Full presentation:
|
9
|
Resverlogix Corp.
|
Nov 16, 2019 12:58PM
|
Re: Full presentation:
|
1
|
Resverlogix Corp.
|
Nov 16, 2019 01:07PM
|
Re: fully adjudicated?
|
7
|
Resverlogix Corp.
|
Apr 07, 2019 08:42PM
|
Re: fully adjudicated?
|
2
|
Resverlogix Corp.
|
Apr 07, 2019 09:01PM
|
Re: fully adjudicated?
|
1
|
Resverlogix Corp.
|
Apr 19, 2019 10:57AM
|
Re: Fun and games on StockTwits...
|
7
|
Resverlogix Corp.
|
Sep 13, 2019 03:40PM
|
Re: Futilitcy analysis
|
3
|
Resverlogix Corp.
|
May 12, 2017 11:23AM
|